United Therapeutics Corp (UTHR) Tops Q2 EPS Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $608.49 +1.19%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
United Therapeutics Corp (NASDAQ: UTHR) reported Q2 EPS of $1.49, $0.96 better than the analyst estimate of $0.53. Revenue for the quarter came in at $183.75 million versus the consensus estimate of $180.84 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Therapeutics Corp. (UTHR) PT Raised to $768 at BTIG
- PureCycle Technologies, Inc. (PCT) Tops Q3 EPS by 25c
- North American Construction (NOA) Misses Q3 EPS by 27c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
